Role of Somatodendritic 5‐HT Autoreceptors in Modulating 5‐HT Neurotransmission a

ABSTRACT: A very important element controlling serotonin (5‐HT) release throughout the brain is the 5‐HT1A autoreceptor present on the soma and dendrites of 5‐HT neurons since it exerts a negative feedback influence on their firing activity. This 5‐HT1A autoreceptor receives an increased activation by endogenous 5‐HT at the beginning of a treatment with a selective 5‐HT reuptake inhibitor (SSRI) and, consequently, a decreased 5‐HT neuronal firing activity is obtained. As the SSRI treatment is prolonged, the 5‐HT1A autoreceptor desensitizes and firing activity is restored in the presence of the SSRI. That this adaptive change underlies, at least in part, the delayed therapeutic effect of SSRI in major depression is supported by the acceleration of the antidepressant response by the concomitant administration of the 5‐HT1A autoreceptor antagonist pindolol with SSRIs.

[1]  F. Bloom,et al.  Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. , 1972, Life sciences. Pt. 1: Physiology and pharmacology.

[2]  M. Tome,et al.  Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency , 1997, International clinical psychopharmacology.

[3]  D. Dorsa,et al.  Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors , 1992, Molecular and Cellular Neuroscience.

[4]  Gilles Bonvento,et al.  Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain , 1992, Neuroscience Letters.

[5]  G. Aghajanian,et al.  Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance , 1984, Brain Research.

[6]  G. Aghajanian,et al.  Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin , 1977, Neuropharmacology.

[7]  M. Millan,et al.  Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. , 1993, The Journal of pharmacology and experimental therapeutics.

[8]  B. Jacobs,et al.  Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. , 1994, The Journal of pharmacology and experimental therapeutics.

[9]  P. Celada,et al.  Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus. , 1994, European journal of pharmacology.

[10]  P. Blier,et al.  Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration. , 1996, The Journal of pharmacology and experimental therapeutics.

[11]  S. J. Starkey,et al.  5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphénucleus , 1994, Neuropharmacology.

[12]  C. de Montigny,et al.  Short‐term lithium treatment enhances responsiveness of postsynaptic 5‐HT1A receptors without altering 5‐HT autoreceptor sensitivity: An electrophysiological study in the rat brain , 1987, Synapse.

[13]  V. Pérez,et al.  Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. , 1994, Archives of general psychiatry.

[14]  G. Aghajanian,et al.  Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices , 1983, Brain Research.

[15]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Blier,et al.  Pre‐ and post‐synaptic effects of the 5‐HT3 agonist 2‐Methyl‐5‐HT on the 5‐HT system in the rat brain , 1995, Synapse.

[17]  M. Millan,et al.  Inhibition of the constitutive activity of human 5‐HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635 , 1997, British journal of pharmacology.

[18]  F. Borsini,et al.  The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex , 1994, Neuropharmacology.

[19]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[20]  P. Blier,et al.  Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. , 1995, Journal of clinical psychopharmacology.

[21]  G. W. Price,et al.  The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig. , 1997, European journal of pharmacology.

[22]  P. Blier,et al.  Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive–compulsive disorder , 1999, Biological Psychiatry.

[23]  F. Hery,et al.  In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat , 1982, Brain Research Bulletin.

[24]  P. Blier,et al.  Effect of repeated electroconvulsive shocks on serotonergic neurons. , 1992, European journal of pharmacology.

[25]  S. Haj-Dahmane,et al.  Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. , 1990, The Journal of pharmacology and experimental therapeutics.

[26]  V. Pérez,et al.  Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment , 1997, The Lancet.

[27]  L. D. van de Kar,et al.  Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. , 1996, The Journal of pharmacology and experimental therapeutics.

[28]  J. C. Winter,et al.  [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe. , 1997, European journal of pharmacology.

[29]  C. de Montigny,et al.  Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain , 1996, Neuropsychopharmacology.

[30]  G. Aghajanian,et al.  (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. , 1986, European journal of pharmacology.

[31]  S. Maayani,et al.  Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[32]  C. de Montigny,et al.  Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain , 1987, Synapse.

[33]  P. Blier,et al.  Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors , 1995, Neuropsychopharmacology.

[34]  C. Montigny,et al.  5-HT1D Receptors Regulate 5-HT Release in the Rat Raphe Nuclei , 1995, Neuropsychopharmacology.

[35]  B. Jacobs,et al.  Electrophysiological evidence against negative neuronal feedback from the forebrain controlling midbrain raphe unit activity , 1977, Brain Research.

[36]  J. Stamford,et al.  The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT1A and 5-HT 1B D receptor antagonists , 1995, Neuroscience Letters.

[37]  G. Aghajanian,et al.  Collateral inhibition of serotonergic neurones in the rat dorsal raphe nucleus: Pharmacological evidence , 1978, Neuropharmacology.

[38]  G. Aghajanian,et al.  Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons. , 1987, European journal of pharmacology.

[39]  G. Aghajanian,et al.  Rophe neurons: effect of tricyclic antidepressant drugs. , 1972, Brain research.

[40]  C. Dourish,et al.  Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. , 1988, European journal of pharmacology.

[41]  M. Hamon,et al.  Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  C. Sotelo,et al.  Direct Immunohistochemical Evidence of the Existence of 5‐HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei , 1990, The European journal of neuroscience.

[43]  R. Nicoll,et al.  Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. , 1987, The Journal of physiology.